| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1991PNAS...88.4626S |
| P356 | DOI | 10.1073/PNAS.88.11.4626 |
| P932 | PMC publication ID | 51718 |
| P698 | PubMed publication ID | 1905011 |
| P5875 | ResearchGate publication ID | 21251000 |
| P2093 | author name string | Verma IM | |
| Scharfmann R | |||
| Axelrod JH | |||
| P2860 | cites work | Retrovirus-mediated transduction of adult hepatocytes | Q33570031 |
| An alternative approach to somatic cell gene therapy | Q33571138 | ||
| Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses | Q33619761 | ||
| Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges | Q33644899 | ||
| Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs | Q33671665 | ||
| Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos | Q33880924 | ||
| Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer | Q34585324 | ||
| Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region | Q36887904 | ||
| Analysis of the mouse dhfr promoter region: existence of a divergently transcribed gene | Q36891514 | ||
| Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene | Q36924243 | ||
| Progress toward human gene therapy | Q37940989 | ||
| Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells | Q41904037 | ||
| Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. | Q44190240 | ||
| Factors affecting long-term stability of Moloney murine leukemia virus-based vectors | Q45846747 | ||
| Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse | Q52273129 | ||
| Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. | Q54441070 | ||
| Gene Therapy | Q57075913 | ||
| Site-specific gene expression in vivo by direct gene transfer into the arterial wall | Q68354939 | ||
| Recombinant gene expression in vivo within endothelial cells of the arterial wall | Q69206990 | ||
| Implantation of vascular grafts lined with genetically modified endothelial cells | Q69633337 | ||
| The contractility of fibroblasts in a collagen lattice is reduced by corticosteroids | Q71302140 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mouse fibroblast | Q104416140 |
| P304 | page(s) | 4626-4630 | |
| P577 | publication date | 1991-06-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants | |
| P478 | volume | 88 |
| Q40657033 | A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins |
| Q38791508 | A human beta cell line with drug inducible excision of immortalizing transgenes |
| Q40952202 | A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line |
| Q48233698 | A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors |
| Q33933129 | Adeno-associated virus as a gene delivery system |
| Q36179657 | Adenoviral vectors: development and application |
| Q43836200 | Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice |
| Q34201134 | Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity |
| Q40872589 | An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias |
| Q36697916 | Appropriate in vivo expression of a muscle-specific promoter by using avian retroviral vectors for gene transfer [corrected] |
| Q54734812 | Asialofetuin liposomes for receptor-mediated gene transfer into hepatic cells. |
| Q45874723 | Autologous, orthotopic thyroid follicular cell transplantation: a surgical component of ex vivo somatic gene therapy |
| Q41222750 | Bilirubin glucuronidation by intact Gunn rat fibroblasts expressing bilirubin UDP-glucuronosyltransferase |
| Q38358539 | Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition |
| Q34276856 | Biomedical applications of collagen |
| Q43907092 | C3-Tat/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene |
| Q45866923 | Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials |
| Q41601384 | Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes |
| Q48044429 | Cloning and sequence analysis of the immediate promoter region and cDNA of porcine granulocyte colony-stimulating factor |
| Q36700186 | Construction of retroviral vector carrying HSV-tk gene under control of human AFP enhancer core sequence and human pgk promotor |
| Q45880219 | Construction of retroviral vectors to induce strong hepatoma cell-specific expression of cytokine genes |
| Q34352418 | Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts |
| Q64381079 | Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats |
| Q46659741 | Effects of choline and quiescence on Drosophila choline acetyltransferase expression and acetylcholine production by transduced rat fibroblasts |
| Q37374666 | Efficient expression of protein coding genes from the murine U1 small nuclear RNA promoters |
| Q40766074 | Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced wit lentiviral vectors. |
| Q37251114 | Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector |
| Q41221964 | Evaluation of HBV promoters for use in hepatic gene therapy |
| Q45856666 | Evaluation of fibroblast-mediated gene therapy in a feline model of mucopolysaccharidosis type VI. |
| Q53617874 | Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. |
| Q45856281 | Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation. |
| Q36757603 | Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes |
| Q41251287 | Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis |
| Q45773320 | Gene delivery into the brain using virus vectors |
| Q34119491 | Gene therapy for Parkinson's disease: review and update |
| Q64379985 | Gene therapy for hemophilia |
| Q34675871 | Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice |
| Q37300317 | Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo |
| Q40344873 | Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. |
| Q34066344 | Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery |
| Q40785483 | Genetically engineered kidneys |
| Q41764207 | Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral Vector |
| Q40712522 | Glucose 6-phosphate dehydrogenase expression is less prone to variegation when driven by its own promoter |
| Q40985222 | High-titer MSCV-based retrovirus generated in the pCL acute virus packaging system confers sustained gene expression in vivo |
| Q35891440 | Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. |
| Q39577188 | Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. |
| Q70973319 | Human capillary endothelial cells from abdominal wall adipose tissue: isolation using an anti-pecam antibody |
| Q30503430 | Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. |
| Q38837779 | Immortalization of pig fibroblast cells by transposon-mediated ectopic expression of porcine telomerase reverse transcriptase |
| Q40937608 | Improved cationic lipid formulations for in vivo gene therapy |
| Q48529105 | In vivo gene transfer into the adult mammalian central nervous system by continuous injection of plasmid DNA-cationic liposome complex |
| Q36299641 | In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment |
| Q73597581 | Increment of hFIX expression with endogenous intron 1 in vitro |
| Q45862705 | Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. |
| Q39741008 | Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue |
| Q39877349 | Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. |
| Q37354891 | Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma |
| Q24604155 | Intron requirement for expression of the human purine nucleoside phosphorylase gene |
| Q57817759 | Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders |
| Q35051812 | Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction |
| Q42280576 | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain |
| Q52523941 | Long-term histological follow-up of genetically modified myoblasts grafted into the brain. |
| Q35888390 | Long-term production and delivery of human growth hormone in vivo |
| Q39877082 | Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy. |
| Q28587864 | Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts |
| Q36685985 | Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation |
| Q48317110 | Particle bombardment-mediated gene transfer and expression in rat brain tissues |
| Q33705401 | Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease |
| Q74649932 | Piecing together more efficient gene expression |
| Q36460846 | Polymeric nanoparticles for gene delivery |
| Q40442947 | Possible orthopaedic applications of gene therapy |
| Q48672896 | Potential effect of cytokines on transgene expression in primary fibroblasts implanted into the rat brain |
| Q40392730 | Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts. |
| Q35757133 | Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector |
| Q36534906 | Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy |
| Q33968115 | Prodrug activation enzymes in cancer gene therapy |
| Q36680730 | Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation |
| Q36552538 | Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells |
| Q33781921 | Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. |
| Q24802168 | Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue |
| Q36548693 | Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy |
| Q33545312 | Restorative gene therapy approaches to Parkinson's disease |
| Q40838456 | Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I. |
| Q40944434 | Retroviral vectors. From laboratory tools to molecular medicine |
| Q40939227 | Ribozyme-mediated specific gene replacement of the alpha1-antitrypsin gene in human hepatoma cells |
| Q28776784 | Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required |
| Q42161152 | Stable correction of maple syrup urine disease in cells from a Mennonite patient by retroviral-mediated gene transfer |
| Q33888773 | Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system |
| Q37822930 | Strategies for the development of cell lines for ex vivo gene therapy in the central nervous system |
| Q34421635 | Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts |
| Q45884182 | Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors |
| Q45862567 | Sustained gene expression in transplanted skin fibroblasts in rats |
| Q39874498 | Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. |
| Q40015747 | The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation |
| Q35585723 | Tissue engineered small-diameter vascular grafts |
| Q45875232 | Towards gene therapy for haemophilia B using primary human keratinocytes |
| Q36068277 | Towards safe, non-viral therapeutic gene expression in humans. |
| Q36567871 | Transcriptional activation and transformation by FosB protein require phosphorylation of the carboxyl-terminal activation domain |
| Q40656937 | Transformation by Fos proteins requires a C-terminal transactivation domain |
| Q33937612 | Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor-target interactions |
| Q34836871 | Virus-based gene delivery systems |
Search more.